Probability of prostate cancer in Chinese men - Evidencio
Probability of prostate cancer in Chinese men
Prostate health index (PHI) nomogram predicting the probability of prostate cancer in Chinese men with PSA ≤10 ng/mL and normal digital rectal examination (c-index: 0.79).
Autori della ricerca: Zhu Y, Han CT, Zhang GM, Liu F, Ding Q, Xu JF, Vidal AC, Freedland SJ, Ng CF, Ye DW.
Versione: 1.19
  • Pubblico
  • Oncologia
  • {{ modelType }}
  • Algoritmo
  • Dettagli
  • Convalidare
  • Salvare l'input
  • Ingresso di carico
  • {{ toolbarErrorMessage }}

Display
Unità

{{ section.title }}

{{ section.description }}

Calcolare il risultato

Impostare altri parametri per eseguire il calcolo

Probability of prostate cancer:

{{ resultSubheader }}
{{ $t('download_result_availability') }}
slide-left-right {{ $t('scroll_chart') }}
{{ chart.title }}
Intervallo di risultati {{ additionalResult.min }} a {{ additionalResult.max }}

Informazioni condizionali

Il tuo testo è stato modificato. Aggiorna il risultato. Aggiornare

This nomogram provides an objective and quantifiable estimation of cancer risk and offers useful information for consultation. The decision to perform a prostate biopsy not only depends on prostate carcinoma risk, but also on multiple factors, including the patient’s life expectancy, co-morbidity, and preference.

Model performance:
On internal validation using a 200 bootstrap resampled dataset, the nomogram’s corrected AUC was 0.872. The calibration plot showed good correlation between predicted and actual probability. In a separate validation cohort consisting of 230 patients, the AUC of the nomogram was 0.786 (range, 0.678–0.894).

Clinical relevance: 
Zhu et al (2015) simulated clinical decision making by calculating the consequences of applying different criteria in the validation cohort. PSAD biopsy criteria resulted in unnecessary biopsies in 42.6% of cases and missed 28.6% of cancer cases. Using the PHI-nomogram, the authors were able to significantly reduce the number of unnecessary biopsies. For example, at the cutoff of 5%, unnecessary biopsies were reduced to 27% without missing any additional cancer cases.

Reference: Zhu Y, Han CT, Zhang GM, Liu F, Ding Q, Xu JF, Vidal AC, Freedland SJ, Ng CF, Ye DW. Development and external validation of a prostate health index-based nomogram for predicting prostate cancer. Sci Rep. 2015 16;5:15341.


{{ file.classification }}
PRO
Nota
Le note sono visibili solo nel download dei risultati e non vengono salvate da Evidencio.

Questo algoritmo viene fornito a scopo educativo, formativo e informativo. Non deve essere utilizzato a supporto di decisioni mediche o per fornire servizi medici o diagnostici. Leggete il nostro sito completo disclaimer.

Algoritmi sottostanti Parte di
Commenti
Commento
Inserisci un commento
I commenti sono visibili a chiunque

Feedback del algoritmo

Ancora nessun feedback 1 Commento {{ model.comments.length }} Commenti
Su {{ comment.created_at }} {{ comment.user.username }} un autore non più registrato ha scritto:
{{ comment.content }}
logo

Effettuare l'accesso per abilitare le funzionalità di stampa di Evidencio

Per utilizzare le funzioni di stampa di Evidencio, è necessario aver effettuato il login.
Se non si dispone di un account comunitario Evidencio, è possibile creare un account personale gratuito all'indirizzo:

https://www.evidencio.com/registration

Risultati stampati - Esempi 2026-11-15 21:48


Vantaggi del conto comunitario Evidencio


With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.


Esclusione di responsabilità: i calcoli da soli non dovrebbero mai dettare la cura del paziente e non sostituiscono il giudizio professionale.